Research progress of trichorhinophalangeal syndrome type 1 in breast cancer

XU Jingchun; DAI Guihong; WANG Lu; ZHU Xiaowei; YU Hong

doi:10.7619/jcmp.20244478

Journal of Clinical Medicine in Practice > 2025 > 29(6): 143-148. > DOI: 10.7619/jcmp.20244478

XU Jingchun, DAI Guihong, WANG Lu, ZHU Xiaowei, YU Hong. Research progress of trichorhinophalangeal syndrome type 1 in breast cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 143-148. DOI: 10.7619/jcmp.20244478

Citation:

PDF (1207 KB)

Research progress of trichorhinophalangeal syndrome type 1 in breast cancer

Department of Pathology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, Jiangsu, 225300

More Information

Received Date: September 24, 2024
Revised Date: December 15, 2024

Graphical Abstract

Abstract

Abstract

Breast cancer is one of the most common tumors worldwide. Despite significant progress in diagnosis and treatment, the incidence and mortality rates remain high due to its highly invasive and metastatic characteristics. Trichorhinophalangeal syndrome type 1 (TRPS1) is an atypical globin transcription factor-1 (GATA). It plays an important role in regulating cell proliferation and differentiation and tissue growth. Studies have found that TRPS1 is significantly overexpressed in breast cancer and closely related to tumor invasion and metastasis. TRPS1 is specifically expressed in the ductal epithelial cells of breast tissue and closely associated with the differentiation of breast ducts. In recent years, scholars have mainly focused on the role and mechanisms of TRPS1 in the diagnosis and treatment of breast cancer. This review summarized the research progress of TRPS1 in breast cancer, aiming to further analyze its clinical application value in the occurrence, development, diagnosis, and treatment of breast cancer.

FullText(HTML)

References (51)

References

[1]	FU B F, LOU Y M, WU P, et al. Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance[J]. Neoplasia, 2024, 55: 101017. doi: 10.1016/j.neo.2024.101017
[2]	SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[3]	WAKS A G, WINER E P. Breast Cancer Treatment[J]. Jama-Journal of the American Medical Association, 2019, 321(3): 288. doi: 10.1001/jama.2018.19323
[4]	UZUN M, ATAG E, CALISKAN YILDIRIM E, et al. Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy[J]. Sci Rep, 2024, 14(1): 14651. doi: 10.1038/s41598-024-64492-9
[5]	VOJTEK M, MARTINS C B, RAMOS R, et al. Pd(Ⅱ) and Pt(Ⅱ) trinuclear chelates with spermidine: selective anticancer activity towards TNBC-sensitive and-resistant to cisplatin[J]. Pharmaceutics, 2023, 15(4): 1205. doi: 10.3390/pharmaceutics15041205
[6]	秦爱平, 杨艳, 戚庭月. 不同分子亚型的浸润性乳腺癌超声特征与预后分析[J]. 实用临床医药杂志, 2023, 27(24): 26-29, 36. doi: 10.7619/jcmp.20232160
[7]	丛佳, 石杨, 刘远远. 环状RNA同源域相互作用蛋白激酶3促进三阴乳腺癌细胞增殖和迁移的作用机制研究[J]. 实用临床医药杂志, 2022, 26(13): 93-99. doi: 10.7619/jcmp.20220458
[8]	RANGEL R, LEE S C, BAN K H, et al. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression[J]. Proc Natl Acad Sci USA, 2016, 113(48): E7749-E7758.
[9]	HUANG J Z, CHEN M, ZENG M, et al. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1[J]. J Pathol, 2016, 239(2): 186-196. doi: 10.1002/path.4716
[10]	CORNELISSEN L M, DRENTH A P, VAN DER BURG E, et al. TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development[J]. Genes Dev, 2020, 34(3/4): 179-193.
[11]	SU P, HU J, ZHANG H, et al. Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer[J]. Diagn Pathol, 2014, 9: 119.
[12]	SALEM A, WU Y, ALBARRACIN C T, et al. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland[J]. Hum Pathol, 2024, 145: 42-47. doi: 10.1016/j.humpath.2024.01.004
[13]	LUI J W, TSANG J Y, LI J, et al. TRPS1 is a promising marker for all subtypes of breast cancer[J]. Histopathology, 2024, 84(5): 822-836. doi: 10.1111/his.15126
[14]	HU J, SU P, JIAO M, et al. TRPS1 suppresses breast cancer epithelial-mesenchymal transition program as a negative regulator of SUZ12[J]. Transl Oncol, 2018, 11(2): 416-425.
[15]	MOMENI P, GLÖCKNER G, SCHMIDT O, et al. Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type Ⅰ[J]. Nat Genet, 2000, 24(1): 71-74.
[16]	GAI Z B, ZHOU G Y, ITOH S, et al. Trps1 functions downstream of Bmp7 in kidney development[J]. J Am Soc Nephrol, 2009, 20(11): 2403-2411.
[17]	ABUNIMYE D A, OKAFOR I M, OKOROWO H, et al. The role of GATA family transcriptional factors in haematological malignancies: a review: Retraction[J]. Medicine (Baltimore), 2024, 103(18): e38232.
[18]	GAI Z B, ZHOU G Y, GUI T, et al. Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression[J]. J Am Soc Nephrol, 2010, 21(9): 1468-1476.
[19]	ITOH S, KANNO S, GAI Z B, et al. Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells[J]. Genes Cells, 2008, 13(4): 355-363.
[20]	KANNO S, GUI T, ITOH S, et al. Aberrant expression of the P2 promoter-specific transcript Runx1 in epiphyseal cartilage of Trps1-null mice[J]. Exp Mol Pathol, 2011, 90(2): 143-148.
[21]	FANTAUZZO K A, KURBAN M, LEVY B, et al. Trps1 and its target gene Sox9 regulate epithelial proliferation in the developing hair follicle and are associated with hypertrichosis[J]. PLoS Genet, 2012, 8(11): e1003002.
[22]	LIN H Y, ZENG D, LIANG Y K, et al. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies[J]. Oncotarget, 2017, 8(21): 34750-34761.
[23]	LAW T, PIOTROWSKI M J, NING J, et al. Trichorhinophalangeal syndrome type 1(TRPS1) expression in male breast carcinoma[J]. Hum Pathol, 2023, 138: 62-67.
[24]	WANG J, PENG Y, SUN H, et al. TRPS1 and GATA3 expression in invasive breast carcinoma with apocrine differentiation[J]. Arch Pathol Lab Med, 2024, 148(2): 200-205.
[25]	WENDROTH S M, MENTRIKOSKI M J, WICK M R. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin[J]. Ann Diagn Pathol, 2015, 19(1): 6-9.
[26]	RAO M, KHADE S, CHAUDHARY R, et al. Comparison of GATA-3, mammaglobin and GCDFP-15 expression in primary, metastatic and triple negative breast carcinomas: an Indian scenario[J]. Asian Pac J Cancer Prev, 2023, 24(2): 509-515.
[27]	WU Y, CHEN F, PAN L, et al. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours[J]. Pathology, 2024, 56(4): 516-527.
[28]	LIU H Y, SHI J H, PRICHARD J W, et al. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas[J]. Am J Clin Pathol, 2014, 141(5): 648-655.
[29]	MCINTIRE P J, DUCKWORTH L A, VAN ARNAM J, et al. TRPS1, a new promising marker for assessment of distant metastatic breast cancer[J]. Adv Anat Pathol, 2023, 30(6): 380-387.
[30]	PARKINSON B, CHEN W, SHEN T S, et al. TRPS1 expression in breast carcinomas: focusing on metaplastic breast carcinomas[J]. Am J Surg Pathol, 2022, 46(3): 415-423.
[31]	ÁLVAREZ B, MONTERO A, CIÉRVIDE R, et al. Real-world efficacy of postoperative radiotherapy with a moderate dose-escalation for Phyllodes tumors of the breast[J]. Transl Breast Cancer Res, 2023, 4: 19.
[32]	WANG J, WANG W L, SUN H X, et al. Expression of TRPS1 in Phyllodes tumor and sarcoma of the breast[J]. Hum Pathol, 2022, 121: 73-80.
[33]	MOGHBELI M. PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells[J]. Cancer Cell Int, 2024, 24(1): 165.
[34]	BRONSERT P, ENDERLE-AMMOUR K, BADER M, et al. Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface[J]. J Pathol, 2014, 234(3): 410-422.
[35]	龚雪. TRPS1抑制SOX2在乳腺癌细胞干性维持和肿瘤发生起始的转录调控机制研究[D]. 南京: 东南大学, 2019.
[36]	WANG Y Z, ZHANG J, WU L L, et al. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth[J]. Breast Cancer Res, 2018, 20(1): 83.
[37]	AL KAWAS H, SAAID I, JANK P, et al. How VEGF-A and its splice variants affect breast cancer development - clinical implications[J]. Cell Oncol (Dordr), 2022, 45(2): 227-239.
[38]	王宝良, 张玲, 陈铁良, 等. 结直肠癌组织中高迁移率蛋白族1与血管内皮生长因子、微血管密度的相关性研究[J]. 实用临床医药杂志, 2022, 26(21): 80-84, 89. doi: 10.7619/jcmp.20220808
[39]	HU J, SU P, JIA M, et al. TRPS1 expression promotes angiogenesis and affects VEGFA expression in breast cancer[J]. Exp Biol Med (Maywood), 2014, 239(4): 423-429.
[40]	ELSTER D, TOLLOT M, SCHLEGELMILCH K, et al. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells[J]. Nat Commun, 2018, 9(1): 3115.
[41]	SCOTT T G, SATHYAN K M, GIOELI D, et al. TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells[J]. PLoS Genet, 2024, 20(2): e1011159.
[42]	WANG H T, HUANG Y L, YANG Y R. LncRNA PVT1 regulates TRPS1 expression in breast cancer by sponging miR-543[J]. Cancer Manag Res, 2020, 12: 7993-8004.
[43]	ZHANG Y E, STUELTEN C H. Alternative splicing in EMT and TGF-β signaling during cancer progression[J]. Semin Cancer Biol, 2024, 101: 1-11.
[44]	CHEN J Q, BAO Y, LEE J, et al. Prognostic value of the trichorhinophalangeal syndrome-1(TRPS-1), a GATA family transcription factor, in early-stage breast cancer[J]. Ann Oncol, 2013, 24(10): 2534-2542.
[45]	CREIGHTON C J, LI X X, LANDIS M, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features[J]. Proc Natl Acad Sci USA, 2009, 106(33): 13820-13825.
[46]	ALFAROUK K O, STOCK C M, TAYLOR S, et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp[J]. Cancer Cell Int, 2015, 15: 71.
[47]	ZHANG Y S, YANG C, HAN L, et al. Expression of BCRP/ABCG2 protein in invasive breast cancer and response to neoadjuvant chemotherapy[J]. Oncol Res Treat, 2022, 45(3): 94-101.
[48]	ZHU X Z, WONG I L K, CHAN K F, et al. Triazole bridged flavonoid dimers as potent, nontoxic, and highly selective breast cancer resistance protein (BCRP/ABCG2) inhibitors[J]. J Med Chem, 2019, 62(18): 8578-8608.
[49]	HU J, ZHANG H, LIU L, et al. TRPS1 confers multidrug resistance of breast cancer cells by regulating BCRP expression[J]. Front Oncol, 2020, 10: 934.
[50]	YANG J G, LIU X P, HUANG Y C, et al. TRPS1 drives heterochromatic origin refiring and cancer genome evolution[J]. Cell Rep, 2021, 34(10): 108814.
[51]	ZHAO T, ZHANG T R, ZHANG Y, et al. Paclitaxel resistance modulated by the interaction between TRPS1 and AF178030. 2 in triple-negative breast cancer[J]. Evid Based Complement Alternat Med, 2022, 2022: 6019975.

[1]	HU Yurong, XU Jingchao. Perioperative nursing for plasma cell mastitis[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 113-114, 118. DOI: 10.7619/jcmp.201910033
[2]	WANG Lan, DING Yafei. Effect of operation position in reducing intraoperative pressure ulcer in patients with posterior thoracolumbar incision internal fixation operation[J]. Journal of Clinical Medicine in Practice, 2018, (6): 71-74. DOI: 10.7619/jcmp.201806021
[3]	CHEN Hao. Effect of comprehensive protective nursing measures in prevention of lower extremity deep venous thrombosis in perioperation[J]. Journal of Clinical Medicine in Practice, 2017, (8): 156-158. DOI: 10.7619/jcmp.201708046
[4]	WANG Ying. Perioperative nursing cooperation and experience of precise hepatectomy for liver cancer patients[J]. Journal of Clinical Medicine in Practice, 2016, (18): 114-116. DOI: 10.7619/jcmp.201618037
[5]	ZHAO Yunhua. Study on perioperative nursing of patients with uterine fibroids resection[J]. Journal of Clinical Medicine in Practice, 2015, (18): 81-84. DOI: 10.7619/jcmp.201518026
[6]	LI Ruili. Perioperative nursing intervention in elderly patients with laparoscopic cholecystectomy[J]. Journal of Clinical Medicine in Practice, 2015, (12): 78-80,90. DOI: 10.7619/jcmp.201512025
[7]	YANG Jingwen, MO Ru, ZHANG Zhenxiang. Perioperative nursing of patients with artificial hip joint revision[J]. Journal of Clinical Medicine in Practice, 2015, (8): 84-87. DOI: 10.7619/jcmp.201508027
[8]	TAN Ying, ZHONG Ying, LIU Jingmei. Efficacy and safety research of clinical nursing pathway in patients with primary varicose vein of lower limbs in perioperation[J]. Journal of Clinical Medicine in Practice, 2015, (4): 39-41,46. DOI: 10.7619/jcmp.201504013
[9]	JU Zhenjin, ZHU Weiyi, XU Wenqi. Perioperative nursing of surgical treatment of cavovarus feet[J]. Journal of Clinical Medicine in Practice, 2015, (2): 59-61. DOI: 10.7619/jcmp.201502019
[10]	LI Ping. The application of predictive nursing of the gastric cancer in perioperation[J]. Journal of Clinical Medicine in Practice, 2014, (22): 68-70,80. DOI: 10.7619/jcmp.201422021

Cited By

Cited by

Periodical cited type(1)

彭卫卫，钟丽婷，李泽蕾，钟炳娣，聂启鸿. 亮菌口服溶液对肝癌术后患者免疫功能、肝功能及炎性因子的影响. 临床误诊误治. 2023(09): 84-88 .

Other cited types(0)

Get Citation

PDF

XML

Article views (19) PDF downloads (5) Cited by(1)

Turn off MathJax

Article Contents

Abstract

References

Research progress of trichorhinophalangeal syndrome type 1 in breast cancer